Comparative study of continuous intravenous infusional tegafur or 5-fluorouracil combined with oxaliplatin in the treatment of advanced gastric cancer

Chinese Journal of Cancer Prevention and Treatment

Volumn 14, Issue 2, 2007, Pages 136-139

  Wang, Zhe Hai ^a   Chen, Zhen ^a   Li, Chang Zheng ^a   Zhou, Deng Guang ^a   Sheng, Li Jun ^a   Liu, Bo ^a   Guo, Jun ^a   Liu, Jie ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Antineoplastic combined chem. otherapy protocols therapeutic uses; Comparative study; Drug therapy, combination; Fluorouracil therapeutic uses; Oxalates therapeutic uses; Stomach neoplasms drug therapy

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; TEGAFUR;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; STOMACH CANCER; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT;

EID: 77953438445     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Kishimoto T, Imamura H, Furukawa H, et al. Chemotherapy for patients with advanced/recurrent gastric cancer and the practice at our institute [J]. Gao to Kagaku Ryoho, 2005,32(11): 1682-1684.
2. Chinese source.
3. Lordick F, Lorenzen S, Stollfuss J, et al. Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer[J]. Br J Cancer, 2005, 93(2):190-194.
4. Chinese source.
5. Ishikawa T, Mizuno K, Togashi T, et al. Modified pharmacokinetic modulating chemotherapy for progressive gastric cancer accompanied by peritoneal dissemination[J]. Gan to Kagaku Ryoho, 2005,32(4):469-472.
6. Chinese source.
7. Chinese source.
8. Chinese source.
9. Hillcoat B L, McCulloch P B, Figeuredo A T, et al. Clinical Response and Plasma Levels of 5-Fluorouracil in Patients with Colonic Cancer Treated by Drug Infusion[J]. Br J Cancer,1978,38 (6):719-724.
10. Chinese source.
11. Chinese source.